Home > Qtrly Results > ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES
Quarterly Results Analysis [Dec2023]

ZYDUS LIFESCIENCES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for ZYDUS LIFESCIENCES
Please provide your vote to see the results

ZYDUS LIFESCIENCES Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹4,505 Cr ₹4,369 Cr ₹5,140 Cr ₹5,011 Cr ₹4,257 Cr ₹4,006 Cr ₹3,964 Cr ₹3,806 Cr
Expenses ₹3,423 Cr ₹3,305 Cr ₹3,634 Cr ₹3,755 Cr ₹3,406 Cr ₹3,319 Cr ₹3,240 Cr ₹3,088 Cr
Operating Income ₹1,082 Cr ₹1,064 Cr ₹1,505 Cr ₹1,256 Cr ₹851 Cr ₹686 Cr ₹725 Cr ₹718 Cr
Other Income ₹58 Cr ₹136 Cr ₹36 Cr ₹38 Cr ₹144 Cr ₹174 Cr ₹174 Cr ₹79 Cr
Interest ₹20 Cr ₹9 Cr ₹18 Cr ₹28 Cr ₹33 Cr ₹35 Cr ₹34 Cr ₹39 Cr
Depreciation ₹195 Cr ₹184 Cr ₹180 Cr ₹179 Cr ₹182 Cr ₹182 Cr ₹181 Cr ₹185 Cr
Profit Before Tax ₹926 Cr ₹1,007 Cr ₹1,329 Cr ₹486 Cr ₹780 Cr ₹643 Cr ₹681 Cr ₹573 Cr
Profit After Tax ₹712 Cr ₹781 Cr ₹1,113 Cr ₹349 Cr ₹585 Cr ₹506 Cr ₹563 Cr ₹464 Cr
EPS ₹7.80 ₹7.91 ₹10.74 ₹2.93 ₹6.16 ₹5.16 ₹5.06 ₹3.88
Industry Peers & Returns1W1M1Y
ZYDUS LIFESCIENCES -1.2% -5.2% 83.9%
SUN PHARMACEUTICAL INDUSTRIES -2.3% -6.5% 55.3%
CIPLA 4.1% -4.8% 55.6%
DR REDDYS LABORATORIES 4% 0.8% 29.4%
DIVIS LABORATORIES 7.8% 17.4% 20.3%
MANKIND PHARMA 1.3% 7% NA
TORRENT PHARMACEUTICALS 3.9% 5.1% 66.1%
LUPIN 0.6% 0.5% 127.2%
AUROBINDO PHARMA 5.1% 10.9% 87.1%

ZYDUS LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

3.12 %

Y-o-Y

5.83 %

Quarters Revenues % Change
Dec2023 ₹4,505 Cr
3.12
Sep2023 ₹4,369 Cr
-15.00
Jun2023 ₹5,140 Cr
2.57
Mar2023 ₹5,011 Cr
17.70
Dec2022 ₹4,257 Cr
6.28
Sep2022 ₹4,006 Cr
1.04
Jun2022 ₹3,964 Cr
4.17
Mar2022 ₹3,806 Cr -

ZYDUS LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

1.68 %

Y-o-Y

27.15 %

Quarters Operating Profit % Change
Dec2023 ₹1,082 Cr
1.68
Sep2023 ₹1,064 Cr
-29.32
Jun2023 ₹1,505 Cr
19.89
Mar2023 ₹1,256 Cr
47.58
Dec2022 ₹851 Cr
24.01
Sep2022 ₹686 Cr
-5.31
Jun2022 ₹725 Cr
0.96
Mar2022 ₹718 Cr -
Operating Margins
Q-o-Q

-1.40 %

Y-o-Y

20.11 %

Quarters Operating Margin% % Change
Dec2023 24.01%
-1.40
Sep2023 24.35%
-16.87
Jun2023 29.29%
16.88
Mar2023 25.06%
25.36
Dec2022 19.99%
16.70
Sep2022 17.13%
-6.29
Jun2022 18.28%
-3.08
Mar2022 18.86% -

ZYDUS LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-8.85 %

Y-o-Y

21.68 %

Quarters Profit After Tax % Change
Dec2023 ₹712 Cr
-8.85
Sep2023 ₹781 Cr
-29.85
Jun2023 ₹1,113 Cr
219.31
Mar2023 ₹349 Cr
-40.40
Dec2022 ₹585 Cr
15.64
Sep2022 ₹506 Cr
-10.10
Jun2022 ₹563 Cr
21.33
Mar2022 ₹464 Cr -
PAT Margins
Q-o-Q

-11.58 %

Y-o-Y

14.99 %

Quarters PAT Margin(%) % Change
Dec2023 15.8 %
-11.58
Sep2023 17.87 %
-17.50
Jun2023 21.66 %
211.21
Mar2023 6.96 %
-49.34
Dec2022 13.74 %
8.79
Sep2022 12.63 %
-10.99
Jun2022 14.19 %
16.50
Mar2022 12.18 % -

ZYDUS LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-1.39 %

Y-o-Y

26.62 %

Quarters EPS % Change
Dec2023 ₹7.8
-1.39
Sep2023 ₹7.91
-26.35
Jun2023 ₹10.74
266.55
Mar2023 ₹2.93
-52.44
Dec2022 ₹6.16
19.38
Sep2022 ₹5.16
1.98
Jun2022 ₹5.06
30.41
Mar2022 ₹3.88 -

You may also like the below Video Courses